The management of severe aortoiliac occlusive disease: Endovascular therapy rivals open reconstruction  Vikram S. Kashyap, MD, Mircea L. Pavkov, MD, James.

Slides:



Advertisements
Similar presentations
Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.
Advertisements

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.
Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.
Endovascular therapy for acute limb ischemia
Endovascular treatment of internal iliac artery obstructive disease
Vikram S. Kashyap, MD, Ricardo N. Sepulveda, MD, James F
Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts  Thomas Vesely, MD, William DaVanzo,
Increasing efficacy of endovascular recanalization with covered stent graft for TransAtlantic Inter-Society Consensus II D aortoiliac complex occlusion 
Stenting of femoropopliteal lesions using interwoven nitinol stents
Role of simple and complex hybrid revascularization procedures for symptomatic lower extremity occlusive disease  Hasan H. Dosluoglu, MD, Purandath Lall,
Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K
Iliofemoral stenting for venous occlusive disease
Late graft explants in endovascular aneurysm repair
Fifteen years of infrapopliteal arterial reconstructions with cryopreserved venous allografts for limb salvage  Caren Randon, MD, Bart Jacobs, MD, Frederik.
Clinical significance of embolic events in patients undergoing endovascular femoropopliteal interventions with or without embolic protection devices 
Adjunctive use of the superficial femoral vein for vascular reconstructions  Soma Brahmanandam, MD, MPH, Daniel Clair, MD, James Bena, MS, Timur Sarac,
Arne Gerhard Schwindt, MD, Giuseppe Panuccio, MD, Konstantinos P
Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts  Thomas Vesely, MD, William DaVanzo,
The contemporary management of splenic artery aneurysms
Endovascular management of iliac artery occlusions: extending treatment to TransAtlantic Inter-Society Consensus class C and D patients  Christopher D.
Blake A. Hamby, MD, Daniel E. Ramirez, MD, George E
Endovascular native vessel recanalization to maintain limb perfusion after infected prosthetic vascular graft excision  Victor Z. Erzurum, MD, Dan Clair,
Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self- expanding stent graft versus prosthetic femoral-popliteal bypass in the.
Changing pattern of surgical revascularization for critical limb ischemia over 12 years: Endovascular vs open bypass surgery  Toshifumi Kudo, MD, PhD,
Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent  Bao-Ngoc Nguyen,
Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease  Jean-Baptiste Ricco,
Surgical revascularization versus endovascular therapy for chronic mesenteric ischemia: A comparative experience  Marvin D. Atkins, MD, Christopher J.
Flow control technique to prevent distal embolization during mechanical thrombectomy  Mathew Wooster, MD, Daniel Kloda, DO, Jacob Robison, MD, Joseph Hart,
Percutaneous intervention for infrainguinal occlusive disease in women: Equivalent outcomes despite increased severity of disease compared with men  Brian.
Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery.
Amy N. Roach, BS, Sebastian Larion, MS, Sadaf S. Ahanchi, MD, Chad P
The number of patent tibial vessels does not influence primary patency after nitinol stenting of the femoral and popliteal arteries  Jenny J. Lee, MD,
Perioperative outcomes and amputation-free survival after lower extremity bypass surgery in California hospitals, , with follow-up through 2004 
Open versus endovascular revascularization for chronic mesenteric ischemia: Risk- stratified outcomes  Gustavo S. Oderich, MD, Thomas C. Bower, MD, Timothy.
Ying Huang, MD, PhD, Peter Gloviczki, MD, Audra A
Outcomes of reinterventions after subintimal angioplasty
Chetan P. Huded, MD, Philip P. Goodney, MD, Richard J
Lesion types and device characteristics that predict distal embolization during percutaneous lower extremity interventions  Gautam V. Shrikhande, MD,
Thomas S. Huber, MD, PhD, Michael P. Brown, DO, James M. Seeger, MD, W
Kenneth Ouriel, MD, Daniel G. Clair, MD, K
Stenting of the venous outflow in chronic venous disease: Long-term stent-related outcome, clinical, and hemodynamic result  Peter Neglén, MD, PhD, Kathryn.
Endovascular treatment of atherosclerotic popliteal artery disease based on dynamic angiography findings  Chaoyi Cui, MD, PhD, Xintian Huang, MD, Xiaobing.
Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery  Yoshimitsu.
Current efficacy of open and endovascular interventions for advanced superficial femoral artery occlusive disease  Christopher J. Smolock, MD, Javier.
A personal experience with the influence of diabetes and other factors on the outcome of infrainguinal bypass grafts for occlusive disease  Norman R.
Outcomes of reoperative open or endovascular interventions to treat patients with failing open mesenteric reconstructions for mesenteric ischemia  Karina.
Atherectomy offers no benefits over balloon angioplasty in tibial interventions for critical limb ischemia  Kevin E. Todd, BS, Sadaf S. Ahanchi, MD, Christian.
Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: A propensity-matched.
Balloon angioplasty for revision of failing lower extremity bypass grafts  Haitham Ali, MD, Ahmed Elbadawy, MD, Mahmoud Saleh, MD, Ayman Hasaballah, MD 
Toshifumi Kudo, MD, PhD, Fiona A. Chandra, Samuel S. Ahn, MD 
Percutaneous intervention for infrageniculate arterial disease in women may be associated with better outcomes when compared to men  Andrew Tye, BA, Daniel.
Lower extremity bypass vs endovascular therapy for young patients with symptomatic peripheral arterial disease  Mauri J.A. Lepäntalo, MD, Rabih Houbballah,
Eric C. Scott, MD, Andre Biuckians, MD, MPH, Ryan E
Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease  Hasan H.
James T. McPhee, MD, Louis L. Nguyen, MD, MBA, MPH, Karen J. Ho, MD, C
Linda Le, MD, Ashton Brooks, MBBS, Melissa Donovan, MD, Taylor A
Peripheral atherectomy in TransAtlantic InterSociety Consensus type C femoropopliteal lesions for limb salvage  Andrea E. Yancey, MD, David J. Minion,
Infrainguinal arterial reconstructions in patients with aortoiliac occlusive disease: The influence of iliac stenting  Carlos H. Timaran, MD, Scott L.
A personal experience with factors influencing survival after elective open repair of infrarenal aortic aneurysms  Norman R. Hertzer, MD, Edward J. Mascha,
Gregory C. Schmieder, MD, Megan Carroll, BA, BS, Jean M. Panneton, MD 
A comparison of the standard bolia technique versus subintimal recanalization plus Viabahn stent graft in the management of femoro-popliteal occlusions 
Infrapopliteal angioplasty for critical limb ischemia: Relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbs  Kristina A. Giles,
Christopher J. Abularrage, MD, Mark F. Conrad, MD, MMSc, Lauren A
Long-term outcomes of patients undergoing endovascular infrainguinal interventions with single-vessel peroneal artery runoff  Christopher J. Abularrage,
Efficacious use of nitinol stents in the femoral and popliteal arteries  Todd R Vogel, MD, Larry E Shindelman, MD, Gary B Nackman, MD, Alan M Graham, MD 
Defining utility and predicting outcome of cadaveric lower extremity bypass grafts in patients with critical limb ischemia  Catherine K. Chang, MD, Salvatore.
A pilot, prospective evaluation of a direct thrombin inhibitor, bivalirudin (Angiomax), in patients undergoing lower extremity bypass  Vikram S. Kashyap,
The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: A 10-year experience  Toshifumi Kudo, MD, PhD,
Results of second-time angioplasty and stenting for femoropopliteal occlusive disease and factors affecting outcomes  William P. Robinson, MD, Louis L.
Everolimus Drug-Eluting Stents Are Associated With Improved Outcomes for the Treatment of Infrainguinal Bypass Graft Stenoses  Caitlin W. Hicks, MD, MS,
Presentation transcript:

The management of severe aortoiliac occlusive disease: Endovascular therapy rivals open reconstruction  Vikram S. Kashyap, MD, Mircea L. Pavkov, MD, James F. Bena, MS, Timur P. Sarac, MD, Patrick J. O'Hara, MD, Sean P. Lyden, MD, Daniel G. Clair, MD  Journal of Vascular Surgery  Volume 48, Issue 6, Pages 1451-1457.e3 (December 2008) DOI: 10.1016/j.jvs.2008.07.004 Copyright © 2008 The Society for Vascular Surgery Terms and Conditions

Fig 1 (online only) A, Transbrachial aortography documents an aortic occlusion in a 68-year old woman with rest pain. Late images document the presence of distal iliac arteries reconstituted via collaterals (not shown) B, Femoral access is obtained with ultrasound guidance and endovascular recanalization is performed using a hydrophilic guidewire and catheter. Primary stenting using self-expanding nitinol stents with postdeployment balloon angioplasty restores normal pulsatile perfusion to both lower extremities. Bottom panels, Inaudible Doppler signals preoperatively to ankle-brachial indices of 1.0 bilaterally, transmetatarsal and digital waveforms are shown. Journal of Vascular Surgery 2008 48, 1451-1457.e3DOI: (10.1016/j.jvs.2008.07.004) Copyright © 2008 The Society for Vascular Surgery Terms and Conditions

Fig 2 (online only) Distribution of patients undergoing aortobifemoral (ABF; striped bars) bypass and recanalization, percutaneous transluminal angioplasty, and stenting (R/PTAS, dotted bars) classified by TransAtlantic InterSociety Concensus (TASC) criteria. Both groups had similar distribution of extensive aortoiliac occlusive disease treated by either open (ABFB) or endovascular (R/PTAS) techniques. Journal of Vascular Surgery 2008 48, 1451-1457.e3DOI: (10.1016/j.jvs.2008.07.004) Copyright © 2008 The Society for Vascular Surgery Terms and Conditions

Fig 3 A, Kaplan-Meier curve estimates for (A) primary patency, (B) secondary patency, and (C) limb salvage in patients undergoing aortobifemoral (ABF; solid line) bypass vs recanalization, percutaneous transluminal angioplasty, and stenting (R/PTAS, dashed line) over 36 months (standard error <10%). A, Primary patency for ABF bypass was 93%, which was significantly higher than 74% for patients undergoing R/PTAS (P = .002). B, Secondary patency was 97% for patients undergoing ABF bypass vs 95% for R/PTAS. No significant difference was found between groups (P = .3). C, Limb salvage rates were 98% for both groups (P = .97). Journal of Vascular Surgery 2008 48, 1451-1457.e3DOI: (10.1016/j.jvs.2008.07.004) Copyright © 2008 The Society for Vascular Surgery Terms and Conditions

Fig 4 Survival for patients undergoing aortobifemoral (ABF; solid line) bypass vs recanalization, percutaneous transluminal angioplasty, and stenting (R/PTAS, dashed line) was equivalent at 36 months (80%) by Kaplan-Meier analyses. Standard error <10%. Journal of Vascular Surgery 2008 48, 1451-1457.e3DOI: (10.1016/j.jvs.2008.07.004) Copyright © 2008 The Society for Vascular Surgery Terms and Conditions